USANA Health Sciences, Inc. (FRA:USJ)

USANA Health Sciences Statistics

Total Valuation

FRA:USJ has a market cap or net worth of EUR 308.21 million. The enterprise value is 229.19 million.

Market Cap	308.21M
Enterprise Value	229.19M

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.28M
Shares Outstanding	n/a
Shares Change (YoY)	-2.18%
Shares Change (QoQ)	-1.31%
Owned by Insiders (%)	41.22%
Owned by Institutions (%)	55.66%
Float	9.61M

Valuation Ratios

The trailing PE ratio is 21.21 and the forward PE ratio is 10.24.

PE Ratio	21.21
Forward PE	10.24
PS Ratio	0.39
PB Ratio	0.62
P/TBV Ratio	1.47
P/FCF Ratio	19.28
P/OCF Ratio	11.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.43, with an EV/FCF ratio of 14.34.

EV / Earnings	15.77
EV / Sales	0.29
EV / EBITDA	3.43
EV / EBIT	6.37
EV / FCF	14.34

Financial Position

The company has a current ratio of 2.23

Current Ratio	2.23
Quick Ratio	1.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	49.32

Financial Efficiency

Return on equity (ROE) is 3.15% and return on invested capital (ROIC) is 4.69%.

Return on Equity (ROE)	3.15%
Return on Assets (ROA)	3.74%
Return on Invested Capital (ROIC)	4.69%
Return on Capital Employed (ROCE)	6.88%
Revenue Per Employee	459,127
Profits Per Employee	8,546
Employee Count	1,700
Asset Turnover	1.31
Inventory Turnover	2.45

Taxes

In the past 12 months, FRA:USJ has paid 25.85 million in taxes.

Income Tax	25.85M
Effective Tax Rate	63.26%

Stock Price Statistics

The stock price has decreased by -53.89% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-53.89%
50-Day Moving Average	18.44
200-Day Moving Average	23.91
Relative Strength Index (RSI)	47.29
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.34

Income Statement

In the last 12 months, FRA:USJ had revenue of EUR 780.52 million and earned 14.53 million in profits. Earnings per share was 0.77.

Revenue	780.52M
Gross Profit	618.03M
Operating Income	35.77M
Pretax Income	40.86M
Net Income	14.53M
EBITDA	59.71M
EBIT	35.77M
Earnings Per Share (EPS)	0.77

Balance Sheet

The company has 124.30 million in cash and n/a in debt, giving a net cash position of 124.30 million.

Cash & Cash Equivalents	124.30M
Total Debt	n/a
Net Cash	124.30M
Net Cash Per Share	n/a
Equity (Book Value)	497.34M
Book Value Per Share	24.72
Working Capital	124.35M

Cash Flow

In the last 12 months, operating cash flow was 26.96 million and capital expenditures -10.97 million, giving a free cash flow of 15.99 million.

Operating Cash Flow	26.96M
Capital Expenditures	-10.97M
Free Cash Flow	15.99M
FCF Per Share	n/a

Margins

Gross margin is 79.18%, with operating and profit margins of 4.58% and 1.86%.

Gross Margin	79.18%
Operating Margin	4.58%
Pretax Margin	5.24%
Profit Margin	1.86%
EBITDA Margin	7.65%
EBIT Margin	4.58%
FCF Margin	2.05%

Dividends & Yields

FRA:USJ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.18%
Shareholder Yield	2.18%
Earnings Yield	4.71%
FCF Yield	5.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 23, 2016. It was a forward split with a ratio of 2.

Last Split Date	Nov 23, 2016
Split Type	Forward
Split Ratio	2

Scores

FRA:USJ has an Altman Z-Score of 5.09 and a Piotroski F-Score of 4.

Altman Z-Score	5.09
Piotroski F-Score	4